Court File No.:

ONTARIO
SUPERIOR COURT OF JUSTICE

IN THE MATTER OF THE LIBEL AND SLANDER ACT,
R.S.O 1990, c. L. 12

AND IN THE MATTER OF AN INTENDED ACTION

B E T W E EN:

BIE HEALTH PRODUCTS O/B
2037839 ONTARIO LTD.
Plaintiff

-and

THE OFFICE OF THE PRIME MNISTER OF CANADA and
PAUL MARTIN and
THE ATTORNEY GENERAL OF CANADA and
THE MINISTER OF HEALTH OF CANADA and
JIM DASKALOPOULOS and
CANWEST GLOBAL COMMUNICATIONS CORP. and
THE CANADIAN PRESS and
TORSTAR CORPORATION mid
CTV INC. and
CBC BROADCASTING CORPORATION and
CNW GROUP LTD. and
THE ATTORNEY GENERAL OF ONTARIO and
THE MINISTER OF HEALTH AND LONG TERM CARE OF ONTARIO and
GOOGLE CANADA CORPORATION and
YAHOO! CANADA CO. and
BRUNSWICK NEWS INC. and
MEDIRESOURCE INC. and
BELL SYMPATICO and
THE NATIONAL ASSOCIATION OF PHARMACY REGULATORY AUTHOORITIES
and
THE ALBERTA COLLEGE OF PHARMACISTS and
ROGERS PUBLISHING LIMITED and
HEALTHWATCHER.NET INC. and
DR. TERRY POLEVOY. MD and
WEBBY INC.
Defendants

NOTICE OF LIBEL

TAKE NOTICE that pursuant to the Libel and Slander Act, R.S.O. 1990, c.L. 12, the Plaintiff complains about various publications made by the Defendants (attached hereto as Appendices A, C, I), h. F. 0, H, I, J, K, L, M, N. 0, F, Q, H, S and T) as being false, malicious and defamatory of the Plaintiff and their business reputation and interests.

The Plaintiff is BIE Health Products o/b 2037839 ONTARIO LTD. [hereinafter referred to as BIE, whose principal is Richard Beemer, a businessman residing and working in Burlington, Ontario, Canada. BIB which has been referenced by Health Canada in the said publications as BIE Health Products [Canada] — see Appendices A and C. is an Ontario based family owned business that has been created under the laws of the Province of Ontario 1.see Appendix B], and has its principle business address at 5465 Scheuller Crescent, Burlington, Ontario, Canada.

BIE is a closely held small to medium sized family enterprise [SMFII] that the principal — Mr. Richard Beemer, a business man with over 25 years of self-employed experience is professionally dependent on to earn his family income and to assemble wealth for his retirement. BIB eels as the exclusive Canadian, 115 and International Marketing soles agent and call centre for a U.S. based Manufacturer of the GHR product, which is a lawful dietary food supplement under US law that is to the Plaintiff's knowledge not subject to any criminal regulatory enforcement by the US Food and Drug Agency in the U.S.A.

The Plaintiff complains that the false and defamatory publications meant, were intended to mean, and were understood to mean that the Plaintiff and its principal and staff were engaged in illegal activities by importing and selling an illegal drug product to Canadians that posed a significant risk to the health and well-being of Canadians.

The Defendant Paul Martin has failed in his capacity as Prime Minister to respond and protect our client from the malicious conduct and behaviour of Jim Daskalopoulos and other federal and elected officials [see Appendix T] and has personally failed to address rogue bureaucratic and the democratic deficit as promised.

The other two federal governmental Defendants, THE ATTORNEY OENEPJ\L OP CANADA AND THE MINISTER OF HEALTH OF CANADA, should have known that their publications were malicious, false and defamatory in nature in naming BIE Health Products [Canada] and GHR in their Health Canada Warning Press Release without any probable cause under federal criminal authority.

The Public Federal Servant Defendant, Mr. Jim Daskalopoulos, is a Manager of Drug
Compliance Verification & Investigations, working out of the Scarborough office of
Health Canada and on June 7, 2005 at 12.47 pm sent by fax, a draft copy of a Health
Canada Warning Press Release to the Plaintiff and the Plaintiff's Legal Agent [See

Appendices A and C] and has been instrumental in harassing the Plaintiff and the Plaintiff’s business for several years.

The Plaintiff believes that Health Canada and various other governmental organizations deliberately used this Press Release [see Appendices A and C] and their criminal power based authority and associated resources as an additional enforcement method to attempt to destroy the Plaintiff the Plaintiffs business and the Plaintiff’s principal’s personal income and personal wealth.

The Plaintiff believes that the Press Release was done as one of several more recent regulatory assaults on the Plaintiff and its principal's business interests in order to drain their financial resources.

The government Defendants are doing this deliberately to prevent the Plaintiff and its principal the financial capacity to fund a legal challenge to the government’s over two years of targeted and systematic regulatory abuse.

This is a systemic methodology used by Health Canada in conjunction with other agencies to, on a pre-planed basis, destroy Safe’s in Canada that arc limited resourced and refuse to voluntarily comply with what the targeted SMFE’s believe are unlawful and abusive regulatory directives.

The federal regulatory entities and the entire command structure, as well as Parliamentary bodies responsible have been advised on numerous occasions that the Plaintiff believes Health Canada’s ever changing allegations are untrue and not founded on enforceable criminal authority within federal jurisdiction.

The federal authorities have been advised that the Plaintiff operates a Marketing, Sales and Call Centre Agency in Burlington, Ontario, Canada and does not import the FDA approved dietary food supplement GHR product for resale to Canadians.

Health Canada’s staff have deliberately violated the protected rights of the Plaintiff as well as the Plaintiffs principal, Richard Beemer, These rights am protected under the Canadian Charter u/Rights and Freedom, the Canadian Bill c/Rights (1960, C. 44) and the Constitution Act, 1982 (I), the British North America, 1867 and the Statutory Powers Procedure Act R.S.O. 1990, CHAPTER S.22, as well as the British traditional common law Rule of Law covenants dating back centuries.

The other named Defendants should have known that under Canadian law, they must fulfill their obligations in exercising full and proper due diligence in a thorough verification of the alleged facts contained in any Press Release or other information obtained from any third party source whatsoever, before cast blanche publishing an article, depending on it or quoting from it.

The non-governmental Defendants also failed, under Canadian law to properly fulfill their legal duty of contacting the named party or parties to thoroughly investigate the rest of the story and to ensure fair and balanced coverage. According to the Plaintiff’s and the Plaintiff’s agent records there is no record of any attempt by any of the non-government named Defendants to contact the Plaintiff or its agents for the Plaintiffs side of the story prior to publication.

The Plaintiff complains of the following matters in the defamatory publications;

a)	Press Release Dated June 7, 2005 Posted on Internet (Appendix C)

The plaintiff  complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant Health Canada on their website, :

Health Canada is warning consumers not to use GHR-15, which is sometimes labeled as GEIR, due to risks associated with unsubstantiated health claims, hyperthyroidism, and possible interactions and allergic reactions. This product is not authorized for sale in Canada.

OHR- 15, which is available through the Internet in capsule amid powder form, is promoted by BIE Health Products (Canada) as a human growth hormone (HGH) supplement. The company suggests it can cure or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Human growth hormone therapy has not been proven to be effective via oral treatments; therefore people taking GHR-15 are not likely to experience any therapeutic benefits. Health Canada cautions against the self-diagnosis or self-treatment of serious diseases and advisees Canadians that GHR-15 is not approved as a treatment for any of these diseases.

GHR-15 also cause hyperthyroidism, which can lead to increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating, hand tremors, nervousness and anxiety, difficulty sleeping, weight Joss despite increased appetite, increased activity level despite fatigue and weakness. and frequent bowel movements, occasionally with diarrhoea.

The product contains, among other ingredients, several amino acids as well as anterior pituitary and hypothalamic extracts. Based on these ingredients, users of this product could also experience drug or hormone interactions and/or allergic reactions,

b)	Press Release Dated June 7,2005 Posted on Internet (Appendix D)

The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant CanWest Global Communications Corp. in their newspaper The Star Phoenix (Saskatoon), and on their website,  press release

The Star Phoenix and  press release:

Health Canada issued a warning to consumers Tuesday not to use a product labelled GHR-15 or GHR that is sold as a treatment for a wide variety of diseases including cancer and multiple sclerosis.

The department said labelling for the product --  purported to be a human growth hormone supplement - - makes unsubstantiated health claims. It suggests users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powdcr form by BIE Health Products (Canada).

c)        Press Release Dated June 7. 2005 Posted on Several Internet 
           (Appendix 0, E. F, .1, K. and M)

The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant. The Canadian Press on their subscriber’s websites, 
, , , , , , and , . and in their subscribers newspaper The Star Phoenix:

TORONTO— Health Canada issued a warning to consumers Tuesday not to use a product labelled GHR-15 or GHR that is sold as a treatment for a wide variety of diseases including cancer and multiple sclerosis.

The department said labelling for the product -- purported to be a human growth hormone supplement --makes unsubstantiated health claims. It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powder form by BIE Health Products (Canada). Human growth hormone therapy has not been proven to he effective when taken orally and people taking GHR-15 are unlikely to experience any therapeutic benefits, the department said.

GHR-15 can also cause hyperthyroidism, which can lead to a variety of symptoms including increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating and nervousness and anxiety.

Analysis of the product suggests users could also experience drug or hormone  interactions and/or allergic reactions, Health Canada said.

d)	Press Release Dated June 7. 2005 Posted on Internet (Appendix E)
The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant Torstar Corporation on their web site, :

TORONTO (CP)— Health Canada issued a warning to consumers Tuesday not to use a product labelled GHR-15 or GHR that is sold as a treatment for a wide variety of diseases including cancer and multiple sclerosis.

The department said labelling for the product -- purported to be a human growth hormone supplement --makes unsubstantiated health claims. It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powder form by BIE Health Products (Canada). Human growth hormone therapy has not been proven to he effective when taken orally and people taking GHR-15 are unlikely to experience any therapeutic benefits, the department said.

GHR-15 can also cause hyperthyroidism, which can lead to a variety of symptoms including increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating and nervousness and anxiety.

Analysis of the product suggests users could also experience drug or hormone  interactions and/or allergic reactions, Health Canada said.

e)	Press Release Dated June 7. 2005 Posted on Internet (Appendix F)
The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant CTV Inc. on their web site, :

TORONTO (CP) - Health Canada issued a warning to consumers Tuesday not to use a product labelled GHR-15 or GHR that is sold as a treatment for a wide variety of diseases including cancer and multiple sclerosis.

The department said labelling for the product -- purported to be a human growth hormone supplement --makes unsubstantiated health claims. It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powder form by BIE Health Products (Canada). 

The company suggests it can cure cancer or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Health Canada said in a release. It noted GHR-15 is not approved as a treatment for any of these diseases.

Human growth hormone therapy has not been proven to he effective when taken orally and people taking GHR-15 are unlikely to experience any therapeutic benefits, the department said.

GHR-15 can also cause hyperthyroidism, which can lead to a variety of symptoms including increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating and nervousness and anxiety.

Analysis of the product suggests users could also experience drug or hormone  interactions and/or allergic reactions, Health Canada said.

f)	Press Release Dated June 7. 2005 Posted on Internet (Appendix G)

The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant CBC Broadcasting Corporation on their web site,  :

Consumers should not use a product that claims to be a human growth hormone supplement called GHR-15, Health Canada warned Tuesday.

BIE Health Products (Canada) sells GHR-15 pr GHR on the internet in capsule and powder form as a treatment for many diseases including cancer, diabetes, arthritis, heart disease and multiple sclerosis.

The health claims are unsubstantiated, said Health Canada, which has not approved it as a treatment for any of the diseases listed.

Since the hormone therapy has not been shown to work in oral form, people are unlikely to be helped by taking it, Health Canada said.

In fact, users may be at risk of developing hyperthyroidism and other possible interactions and allergic reaction, according to the department’s analysis of the product’s ingredients.

Hyperthyroidism can lead to symptoms including higher heart rate or blood pressure, abnormal heart rhythms, too much sweating, nervousness and anxiety, among others.

The department said labelling for the product -- purported to be a human growth hormone supplement --makes unsubstantiated health claims. It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powder form by BIE Health Products (Canada). 

The company suggests it can cure cancer or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Health Canada said in a release. It noted GHR-15 is not approved as a treatment for any of these diseases.

Human growth hormone therapy has not been proven to he effective when taken orally and people taking GHR-15 are unlikely to experience any therapeutic benefits, the department said.

GHR-15 can also cause hyperthyroidism, which can lead to a variety of symptoms including increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating and nervousness and anxiety.

Analysis of the product suggests users could also experience drug or hormone  interactions and/or allergic reactions, Health Canada said.

g)	Press Release Dated June 7.2005 Posted on Internet (Appendix H) 

The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Defendant CNW Group Ltd. on their website,  :

Health Canada is warning consumers not to use GHR-l5, which is sometimes labelled as GHR, due to risks associated with unsubstantiated health claims, hyperthyroidism, and possible interactions and allergic reactions. This product is not authorized for sale in Canada. 

GHR-15. which is available through the Internet in capsule and powder form, is promoted by BlE Health Products (Canada) as a human growth hormone (HGH) supplement. The company suggests it can cure or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis. Human growth hormone therapy has not been proven to be effective via oral treatments; therefore people taking GHR-15 are not likely to experience any therapeutic benefits. Health Canada cautions against the self-diagnosis or self-treatment of serious diseases and advises Canadians that GHR-15 is not approved as a treatment for any these diseases,

GHR-15 can also cause hyperthyroidism, which can lead to increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating, hand tremors,, nervousness and anxiety, difficulty sleeping, weight loss despite increased appetite, increased activity level despite fatigue and weakness, and frequent bowel movements, occasionally with diarrhoea.

The product contains, among other ingredients, several amino acids as well as anterior pituitary and hypothalamic extracts. Based on these ingredients, users of this product could also experience drug or hormone interactions and/or allergic reactions.

       h)    	Press Release Dated June 7, 2005 Posted on Internet (Appendix I)

The plaintiff complains of the following matters appearing in a Juno 7,2005 press release and published by the Defendant Ministry of Health and Long-Term Care (Ontario) on their website, 

Health Canada is warning consumers not to use GHR-15, which is sometimes labelled as GHR, due lo risks associated unsubstantiated health claims, hyperthyroidism, and possible interactions and allergic reactions. This product is not authorized for sale in Canada. 

GHR-15, which is available through tIme Internet in capsule and powder form, is promoted by BIE Health Products (Canada) as a human growth hormone (HGH) supplement. The company suggests it can cure or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis. Human growth hormone therapy has not been proven to be effective via oral treatments; therefore people taking GHR-15 are not likely to experience any therapeutic benefits. Health Canada cautions against the self-diagnosis or self-treatment of serious diseases and advises Canadians that GHR-15 is not approved as a treatment for any of these diseases.

GHR-15 can also cause hyperthyroidism, which can lead to increased heart rate, elevated blond pressure, abnormal heart rhythms, excessive sweating, hand tremors, nervousness and anxiety, difficulty sleeping, weight loss despite increased appetite, increased activity level despite fatigue and weakness, and frequent bowel movements, occasionally with diarrhoea.

The product contains, among other ingredients, several amino acids as well as anterior pituitary and hypothalamic extracts. Based on these ingredients, users of this product could also experience drug or hormone interactions and/or allergic reactions.

i)	   Press Release Dated June 7. 2005 Posted on Internet (Appendix J)

The plaintiff complains oft he following matters appearing in a June 7, 2005 press release and published by the Google Canada Corporation on their website,  :

TORONTO (CT) - Health Canada issued a warning to consumers Tuesday not to use a product labelled GHR-15 or GHR that is sold as a treatment for a wide variety of diseases including cancer and multiple sclerosis.

The department (Health Canada) said labelling for the product - purported to he a human growth hormone supplement makes unsubstantiated health claims. It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powder form by BIB Health Products (Canada). 

The company suggests it can cure or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Health Canada said in a release. It noted GHR-15 is not approved as a treatment for any of these diseases.

Human growth hormone therapy has not been proven to be effective when taken orally and people taking GHR-15 are unlikely to experience any therapeutic benefits, the department said.

GHR-15 can also cause hyperthyroidism which can lead to a variety of symptoms including increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating end nervousness and anxiety.

Analysis of the product suggests users could also experience drug or hormone interactions and/or allergic reactions, Health Canada said.

     j)	   Press Release Dated June 7. 2005 Posted on Internet (Appendix K)

The plaintiff complains of the following matters appearing in a June 7, 2005 press release and published by the Yahoo! Canada Co. on their website,  :

TORONTO (CP) - Health Canada issued a warning to commsuulers Tuesday not to use a product labelled GHR-l 5 or OHR that is sold as a treatment for a variety of diseases including cancer and multiple sclerosis.

The department .said labelling for the product - purported to he a human hormone supplement - makes unsubstantiated health claims, It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product.

GHR-15, which is not authorized for sale mm Canada, is sold over the Internet in capsule and powder form by BIE Health Products (Canada).

The company suggests it can cure or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Health Canada said in a release. It noted OUR-IS is not approved as a treatment for any of these diseases,

Human growth hormone therapy has not been proven to be effective when taken orally and people taking OUR-IS axe unlikely to experience any therapeutic  benefits, the department said.

GHR-15 can also cause hyperthyroidism, which can lead to a variety of symptoms including increased heart rate, elevated blood pressure abnormal heart rhythms excessive sweating and nervousness and anxiety.

Analysis of the product suggests users could also experience drug or hormone interactions and/or allergic reactions, Health Canada said.

j)	Press Release Dated June 28, 2005 Posted on Internet (Appendix L)

The plaintiff complains of the following matters appearing in a June 28, 2005
press release and published by the Brunswick News Inc. on their website,  :

Health Canada is warning consumers not to use GHR-15, which is sometimes labelled as GHR, due to risks associated with unsubstantiated health claims, hyperthyroidism, and possible interactions and allergic reactions. This product is not authorized for sale in Canada.

GHR-15, which is available through the Internet in capsule and powder form, is promoted by BIE Health Products (Canada) as a human growth hormone (HGH) supplement. The company suggests it can cure or help prevent a variety of diseases, including cancer. diabetes, arthritis, heart disease, and multiple sclerosis. Human growth hormone therapy has not been proven to be effective via oral treatments; therefore people taking GHR-I5 are not likely to experience any therapeutic benefits. Health Canada cautions against the self-diagnosis or self-treatment of serious diseases and advises Canadians that GHR-15 is not approved as a treatment for any of these diseases.

GHR-15 can also cause hyperthyroidism, which can lead to increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating, hand tremors, nervousness and anxiety, difficulty sleeping, weight loss despite increased appetite, increased activity level despite
fatigue and weakness, and frequent bowel movements, occasionally with diarrhoea.

The product contains among other ingredients, several amino acids as well as anterior pituitary and hypothalamic extracts, Based on these ingredients, users of this product could also experience drug or interactions and/or allergic reactions. 

l)	  Press Release Dated Jane 29. 2005 Posted on Internet (Appendix M) 

The plaintiff complains of the following matters appearing in a June 29, 2005 press release and published by the Defendants Bell Canada and MediResources Inc. on their website,  

TORONTO (CP) - Health Canada issued a warning to consumers Tuesday not to use a product labelled GHR-15 or GHR that is sold as a treatment for a wide variety of diseases including cancer and multiple sclerosis.

The department (Health Canada) said labelling for the product - purported to be a human growth hormone supplement - makes unsubstantiated health claims It suggested users risk developing hyperthyroidism as well as possible interactions and allergic reactions by taking the product,

GHR-15, which is not authorized for sale in Canada, is sold over the Internet in capsule and powder form by B1E Health Products (Canada).

The company suggests it can cure or help prevent a variety of diseases including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Health Canada said in a release. It noted GHR-15 is not approved as a treatment for any of these diseases.

Human growth hormone therapy has not been proven to be effective when taken orally and people taking GHR-l S are unlikely to experience any therapeutic benefits, the department said.

GHR-15 can also cause hyperthyroidism, which can lead to a variety of symptoms including increased heart rate, elevated blood pressure, abnormal heart rhythms, excessive sweating and nervousness and anxiety.

Analysis of time product suggests misers could also experience drug or hormone interactions and/or allergic reactions, Health Canada said.

              m)	Press Release Dated June 8, 2005 Posted on Intermet (Appendix N)

The plaintiff complains of the matters appearing in a June 8, 2005 press release and published by the Defendant National Association of Pharmacy Regulatory Authorities on their website,  :

Health Canada is warning consumers not to use GHR-15, which is sometimes labelled as GHR, due to risks associated with unsubstantiated health claims, hyperthyroidism, and possible interactions and allergic reactions. This product is not authorized for sale in Canada

GHR-15 which is available through the Internet in capsule and powder form, is promoted by BIE Health Products (Canada) as a human growth hormone (HGH) supplement. The company suggests it can cure or help prevent a variety of diseases, including cancer, diabetes, arthritis, heart disease, and multiple sclerosis, Human growth hormone therapy has not been proven to be effective via oral treatments; therefore people taking GHR-I S are not likely to experience any therapeutic benefits. Health Canada cautions against the self-diagnosis or self-treatment of serious diseases and advises Canadians that 0MB-IS is not approved as a treatment for any of these diseases.

GHR-15 can also cause hyperthyroidism, which can lead to increased heart rate, elevated blood pressure, abnormal heart rhythmss, excessive sweating, hand tremors, nervousness and anxiety, difficulty sleeping, weight loss despite increased appetite, increased activity level despite fatigue and weakness and frequent bowel movements, occasionally with diarrhoea.

The product contains, among other ingredients, several amino acids as well as anterior pituitary and hypothalamic extracts. Based on those ingredients, users of this product could also experience drug or hormone interactions and/or allergic reactions.

      n)	       Press Release Dated June 7, 2005 Posted on Internet (Appendix O)

The plaintiff complains of following matters appem’ing in a June 7,2005 press release and published by the Defendant Alberta College of Pharmacists on their website,  

Health Canada is warning consumers not to use GHR-15 (sometimes labelled as GHR) due to risks associated with unsubstantiated health claims, hyperthyroidism, and possible interactions and allergic reactions.

This product is not authorized for sale in Canada. However we have notified you of the Health Canada advisory in case your patients/clients have questions.

GHR-15  is available through time Internet in capsule and powder form and is promoted by BIE Health Products (Canada) as a human growth hormone (HGH) supplement.

o)	Press Release Dated June 10, 2005 Posted on Internet (Appendix P)

The plaintiff complains of the following matters appearing in a June 10, 2005 press release and published by the Defendant Rogers Publishing Limited on their website,  :

Health Canada has issued a warning to consumers to avoid GHR-15 (also known as (GHR). This product, sold through the Internet, is not authorized for sale in Canada. It is being promoted by BIE Health Products (Canada) as a human growth hormone supplement. The company claims it Can cure or help prevent a variety of diseases (e.g., cancer, diabetes, arthritis, heart disease,  multiple sclerosis). These health claims are unsubstantiated, In addition, the product nay be associated with the development of hyperthyroidism. GHR-15 also contains several amino acids as well as anterior pituitary and hypothalamic extracts, which could lead to drug or hormone interactions mid/or allergic reactions.

	p)	E-Blast Sent  June 8, 2005 (Appendix O)

The plaintiff complains of an e-blast sent on June S, 2005 by the defendant Dr. Terry
Polevoy:

I feel that it is important for the committee members to recognize the fact that there were many people who testified who have questionable credentials and represent nothing more than scam artists. His ads appeared in health food magazines for years and were easy to spot. They also made dubious claims.

It took years for Health Canada to take action against them. His reaction above is par for the course.

The health freedom brigade led by Trueman Tuck, who also spoke to your Committee, has backed his company. Tuck, as you may know, also backed Nick Jerch in his scheme to defraud he public by selling erectile dysfunction herbs that contained the same ingredients in Viagra and Cialis.  Jerch is still in business even after Health Canaada’s actions.

Richard Beemer’s company BIE was charged this week by Health Canada.

q)	Press Release Dated June 30, 2005 Posted on Internet (Appendix R)

The plaintiff complains of the following matters appearing in a June 30, 2005 press release and published by the Defendant HealthWatcher.Net Inc. on their website,  :

www.healthwatcher.net press release:

no they didn’t take action because of deceptive marketing even though the complaints have been compiling for years against BIE Health. Even the Competition Bureau has done nothing to stop these scammers And don’t forget this company is backed by Trueman Tuck, of the FriendsofFreedom.com, And another thing, the bloody BieHealth.ca web site is still up and it still makes false claims. They are also located in the U.S. doing business as GHRWarehouse.com. That really gives it a great name!   NOT…

The Defendants’ defamatory publications falsely and maliciously convey meanings that are severely defamatory and damaging to the Plaintiff’s business. The Defendants have recklessly disregarded the effect the defamatory publications would have on time Plaintiff’s business.

The Plaintiff hereby demands that the Defendants remove the defamatory publications from all i their media sources, websites, archive, and distribution systems and refrain from making any further false and defamatory statements of and concerning the Plaintiff and or their business.

The Plaintiff also hereby demands a full-published retraction correcting the errors on a format pre-approved by the Plaintiff and distributed in a manner equal in priority as the initial publications. This apology shall, immediately after written approval ms made by the Plaintiff be published by the Defendants and with the same prominence and circulation as the defamatory publications.

The plaintiff will require auditable verification of distribution to all sources and networks and copies in written, video and audio formats containing both time original publications as well as the retraction and apology.

The Plaintiff hereby demand that the Defendants preserve all documents, records and information pertaining to the preparation of the defamatory publications. Such documents, records and information include: all notes, correspondence, memoranda or other documents (electronic and hard copy); all third party documents (whether provided by third parties or obtained from third parties); all internal and external electronic messages including transmissions that would be recorded or stored on a back-up system (e.g. archives) or stored on electronic media (e.g. hard drives, disks or tapes);  and, any other documents, records or information pertaining to the publications in issue.

Issued: July18, 2005 _____ ________per [Trueman Tuck]

Tucks Professional Services Canada
O/b 1233330 ONTARIO INC.
A Non-Lawyer, Non-Barrister, Non-Solicitor Legal Consulting
Firm

Service at: 199 Front Street, Suites 104-105
Belleville, Ontario, Canada KEN 5115
Mailing at p o Box 22010, Belleville, Ontario Canada KKN 5~

Legal & Political Rights Advocate – Trueman Tuck

Tel: (613) 968-3001
Fax (613) 968-3215
Email: Advocate_trueman@taxtyranny.ca
Legal Agent for the Plaintiff